DJIA 16,399.67 19.26 0.12%
NASDAQ 4,316.07 57.64 1.35%
S&P 500 1,904.01 17.25 0.91%
market minute promo

Novartis (NYSE: NVS)

87.90 1.27 (1.47%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVS $87.90 1.47%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $86.58
Previous Close $86.63
Daily Range $86.49 - $87.99
52-Week Range $74.54 - $95.50
Market Cap $213.3B
P/E Ratio 23.41
Dividend (Yield) $2.72 (2.7%)
Ex-Dividend Date
Dividend Pay Date
02/27/14
04/10/14
Volume 1,718,265
Average Daily Volume 1,536,369
Current FY EPS $5.17

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary

Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?

The world's largest pharmaceutical company, Pfizer, looks lost amid its staggering patent cliff problem. Could this experimental breast cancer drug put Pfizer back on track for growth?

Can Valeant's Strong Q3 Entice Allergan?

European ETFs Plunge As Trouble Hits Region's Core

This Drug Could Outsell Medical Marijuana

Three top motley fool analysts weigh in on drugs from Gilead Sciences, Biogen, Bristol-Myers, and Merck that could be bigger sellers than medical marijuana.

Roche Reports Strong Sales Results for 9 Months of 2014 - Analyst Blog

Novartis Presents Encouraging Data on Leukemia Candidate - Analyst Blog

Best European Stock Ideas Today

Why Teva Pharmaceutical (TEVA) Stock Is Falling Today

Notable Two Hundred Day Moving Average Cross - NVS

Johnson & Johnson and Bristol-Myers Squibb’s New Collaboration Just the Tip of the Iceberg

Bristol-Myers Squibb's Opdivo and Merck's Keytruda are sought after drugs for combination cancer treatments.

See More NVS News...

NVS's Top Competitors

NVS $87.90 (1.47%)
Current stock: NVS
JNJ $99.20 (0.51%)
Current stock: JNJ
GSK $43.61 (-0.14%)
Current stock: GSK
PFE $27.93 (0.36%)
Current stock: PFE